Category:

CMS announced the first mandatory test of shared-risk, outcomes-based payment model and the first initiative to make hospitals financially-responsible for patient recovery, 90-days after a knee or hip replacement surgery…The landmark program, Comprehensive Care for Joint Replacement, goes into effect April 1, 2016. Patient engagement and care coordination technology will be key to helping hospitals meet cost containment requirements…can lead to lower costs and increased healthcare quality…Healthcare institutions and leaders should know five items to move forward into the coordinated care initiative:

1. 789 hospitals will be impacted
2. 500,000 patients can participate, annually
3. Quality matters. Hospitals must adhere to strict quality metrics and keep down care costs from admissions to 90 days after discharge
4. Hospitals can donate $1,000 per Medicare beneficiary for patient engagement IT and services
5. CMS will provide incentives for Patient Reported Outcomes

Years before Theranos…came under harsh public scrutiny in October, a military official raised concerns that the secretive company was violating federal law…E-mail correspondence obtained by the Post reveals that an official evaluating Theranos’s signature blood-testing technology for the Department of Defense sounded the alarm in 2012 and launched a formal inquiry with the Food and Drug Administration about the company’s intent to distribute its tests without FDA clearance — a problem that has resurfaced this year, leading Theranos to temporarily stop offering almost all of its tests...In October, a Wall Street Journal investigation revealed the company was running most of its tests on devices made by other firms instead of its own “breakthrough” technology. The Journal reported that former Theranos employees and executives of Safeway had questioned the accuracy of the tests.

Only half of small urban hospitals have two-factor authentication capability…Fewer than half of U.S. hospitals support an infrastructure capable of two-factor authentication, The Office of the National Coordinator for Health IT reported…while 35 percent of critical access hospitals and 40 percent of small rural hospitals report the lowest levels of capability…Two-factor authentication requires users to give at least one other form of identification beyond username and password to get access to electronically protected information, such as a PIN and fingerprint or voice recognition…The process is a low-cost, effective way to meet HIPAA standards, but not enough hospitals have implemented it into their cybersecurity plans…cybersecurity experts assert reported levels of adoption are still drastically low, given the steady rise in healthcare data breaches and the increase in hackers targeting the healthcare industry…Some states are above the bar on establishing two-factor authentication. Ohio raked at the top with 93 percent adoption..Vermont, with 83 percent…Delaware, with 81 percent…On the other hand, Montana, with 19 percent, North Dakota, with 23 percent, and Maine, with 26 percent, saw the lowest percentages…

Dr. Jessica Mega…medical director of Google Life Sciences…to lead the new firm’s ambitious quest to analyze genomic, molecular, and imaging big data from 10,000 volunteers to figure out what it means to be healthy — the so-called baseline study…Its experts try to turn blue-sky ideas into products by cross-pollinating medicine, engineering, and data science…I’m normally around physicians and patients. Now I spend my days with amazing engineers. The things you hear around here are “try to fail fast,” and “let’s just try ideas.” What I’ve taught myself to do is first say “yes” and try to be very open, then get analytical and move to a point where we’re being strategic and tactical…The way I think about it is trying to understand more about a given individual so they get the right treatment, get the right medications, and avoid the side effects. We’re trying to figure out ways to help empower people so that they don’t need to spend as much time in hospitals…People don’t want a lot of unnecessary, expensive, cumbersome, inaccurate tests. But we’re working to come up with things that provide actionable information.

There's a very common drug-policy talking point that's meant to convey the absurdity of the war on drugs: Alcohol is more dangerous than marijuana, even though alcohol is legal and marijuana is not…Perhaps the biggest supporting evidence for this point is a 2010 study published in The Lancet that ranked alcohol as the most dangerous drug in the United Kingdom… Although drug policy experts generally don't dispute the assertion that alcohol is more dangerous than pot, the study, led by…David Nutt, is quite controversial. Experts see the rankings as deeply flawed, largely because they present the harms that come from drugs in a rather crude, one-dimensional manner. Even Nutt has acknowledged that the study is imperfect…There probably isn't a perfect way to evaluate and present all drug harms. Researchers will always need to balance making information simple and accessible for policymakers and the public with the inherent complexity of drugs and their effects. This makes the task of building scientific drug policies very challenging…The analysis may be flawed, but its simplicity and accessibility have won over many policy circles.

US health care spending increased 5.3 percent to $3.0 trillion in 2014. On a per capita basis, health spending was $9,523 in 2014, an increase of 4.5 percent from 2013. The share of gross domestic product devoted to health care spending was 17.5 percent, up from 17.3 percent in 2013. The faster growth in 2014 that followed five consecutive years of historically low growth was primarily due to the major coverage expansions under the Affordable Care Act, particularly for Medicaid and private health insurance, which contributed to an increase in the insured share of the population…growth in total retail prescription drug expenditures accelerated sharply, increasing 12.2 percent to $297.7 billion…The strong growth in prescription drug expenditures in 2014 was caused by increased spending on new medicines, a smaller impact from patent expirations than in previous years, and price increases for brand-name drugs. The single largest driver of growth in specialty drug spending in 2014 was the impact of new treatments for hepatitis C, which contributed $11.3 billion in new spending.

The Affordable Care Act | Factors Accounting For Growth | Revisions To The National Health Expenditure Accounts | Sponsors Of Health Care | Private Health Insurance | Medicaid | Medicare | Out-Of-Pocket Spending | Retail Prescription Drugs | Hospital Care | Physician And Clinical Services

Eli Lilly's plan to close a Swiss laboratory that conducts tests and experiments on live animals has caused concerns by a local animal welfare group over the fate of the facility's hundreds of dogs, cats and livestock…company said…it was working to secure new owners for many of the animals as its Elanco animal health company may shut the research center in the Swiss town of Saint-Aubin…Julika Fitzi, a veterinarian and lawyer who works with the group Swiss Animal Protection, worries many may be killed…the laboratory houses about 350 dogs, 170 cats, 280 sheep, cattle and pigs and about 200 mice, figures that Eli Lilly didn't confirm…The expected closure comes as Eli Lilly looks to concentrate some of its Swiss research activities in Basel following its acquisition of the animal health business of Novartis earlier this year…Elanco's spokeswoman…said on Thursday the company will make a final decision on the Saint-Aubin research site later this month…if it is closed the company's primary plan for so-called "companion animals" such as cats and dogs would be "transfer of ownership to other facilities and employee pet owners."

Kids and teens who take prescription medicines to treat attention-deficit hyperactivity disorder may be twice as likely to be bullied as their peers who don’t have this mental health problem… Adolescents who sold their prescribed drugs to other kids – who might want the stimulants for study or diet aids – had more than four times greater odds of being bullied than their peers without ADHD…Our findings show that there is some connection between a prescription for stimulant medications and bullying, even after accounting for the fact that adolescents with ADHD may have difficulties with peers or may have other problem behaviors associated with victimization…

Here’s a chance to lock up some savings…The high cost of hepatitis C drugs may be straining budgets nationwide, but the country can save money if prison inmates are screened and treated for the disease… researchers determined that treatment could lower infection among both prisoners and society…If more inmates are treated, the disease would be less likely to spread within prisons, where an estimated 17 percent of the population is already infected. Beyond that, hepatitis C would be less likely to spread in the wider population once inmates are released. About 1 percent of the general US population is believed to have hepatitis C…screening and treatment would require an added 12.4 percent increase in the health care budgets of state and federal prisons during the first year such an effort is undertaken. But that would eventually decline to an annual budget increase of less than 0.7 percent after 15 years…prices have prompted many public and private payers to restrict access to treatment…a...class action lawsuit was filed earlier this year by two inmates in Massachusetts state prisons for failing to provide hepatitis C treatment to most infected prisoners…

A new poll…Harvard T.H. Chan School of Public Health found significant skepticism about one of the drug industry’s most prevalent talking points. Almost two-thirds of Americans said they did not believe that Medicare negotiating with drug companies to lower prices would lead to fewer medicines being developed. And a majority — 55 percent — believes that even outright price controls wouldn’t slow the flow of new drugs…but the findings suggest that Americans reject a key counterargument the industry makes whenever the specter of government action on drug costs comes up: The current system, while imperfect, allows drug companies to create breakthrough lifesaving medications. They warn that any major changes, particularly more government involvement, could hamper that… poll points to several reasons underlying the public’s attitude…